Medtech commercialisation: your expert-led journey to global markets
We are on a mission to ensure that medical technologies are available to the patients who need them, whilst meeting the needs of the healthcare environment.
We work in expert-led partnerships with innovators across the healthcare sector, providing commercialisation strategy, evidence synthesis and analysis, and value demonstration services, supporting the journey from R&D to market.
If you find yourself asking any of these questions, we can help:
- We have our CE mark, what should we do next?
- How do we get funding?
- How does my product align with national policy objectives?
- What is the right approach for optimal access and reimbursement?
- What evidence do we need to show that our product is both viable and brilliant?
- Who do I need to talk to in health systems? What are their challenges and what are they looking for?
- How can we clearly and consistently communicate the unmet need our innovation resolves?
- How can we defend against competitors?
- What is an appropriate pricing strategy?
- What do local reimbursement considerations mean for my product and pricing strategy?
- How do we sell our innovation to healthcare systems?
Market access for Medtech
Bringing a Medtech innovation to market, be it a device, diagnostic or digital solution, offers both opportunities and challenges. Above all, it is essential to demonstrate that the technology provides clinical and economic value and has a place in treatment pathways alongside, or in preference to, other products.
The route to market for Medtech varies between healthcare systems and product types, and it is crucial to understand the considerations for access and the market landscape relevant to your product.
In England, for example, a technology may be submitted for consideration in NICE’s Medical Technologies Evaluation Programme (MTEP) and potentially routed to medical technologies guidance, diagnostics guidance, or Medtech innovation briefings.
To discuss the opportunities for your innovation with our experts, get in touch using the form below.
Bringing your healthcare innovation to market
As your global commercialisation partner, we offer support throughout the product lifecycle, across all evidence and access hurdles. Our experts can support with:
NICE META Tool – Evidence strategy for commercialisation
Mtech Access have been certified by NICE as a META Tool facilitating organisation. Through the META Tool process we can help you identify gaps in your product development and evidence generation plans. Work with our experts to understand the evidence requirements of key healthcare decision makers, develop a compelling evidence-rich value proposition, and prepare for commercial launch.
Digital conversation aids for Medical Device market access
Conversations with healthcare decision-makers are greatly enhanced with interactive digital visual aids and cost calculators that effectively communicate the clinical and economic value of your technology to their local environment.
Our fully in-house creative teams, which include value consultants, health economists, designers, and developers, collaborate with you to produce robust and visually engaging communication tools that can be programmed to work across all digital devices.
Click the button below to view our demo medical device communication tool.
Why choose Mtech Access to bring your medical device to market?
- We bring extensive experience from our work with top Medical Device companies, supporting their market access and customer engagement strategy
- We understand the nuances of Medtech market access, but can also utilise our in depth experience with Pharmaceutical and other life sciences clients
- Our in-house developers and designers collaborate directly with our value communication experts, health economists, and medical writers to create your materials – delivering a seamless experience
- We ensure the principles and assumptions behind our approach align with the needs of your customers by consulting with a broad network of payers, clinicians, and other stakeholders across global markets
- In the UK we have close relationships with over 100 contracted Associates working in the NHS, who work directly with us on projects to help ensure our market access strategies and messages will resonate with NHS decision-makers
- We combine evidence and creativity to deliver resources that work for your account managers
- We are a full-service Veeva partner, able to leverage Veeva’s full functionality to deliver the best possible experience for your teams and customers
- We are a certified NICE META Tool facilitating organisation; one of a small number of agencies accredited by NICE to help you explore your evidence needs
Featured Case Studies
-
Communicating value to healthcare customers in key markets: A global value story and US-market specific brochures
-
Exploring the US market landscape and developing strategy for a digital health technology
-
Communicating value with a suite of visually impactful materials connected via a digital platform
-
Challenging European policy proposals with an evidence-driven submission on behalf of a cross-industry consortium
-
Exploring funding and reimbursement routes for digital health technologies across EU4, UK and US
-
Understanding the diagnostic market access landscape in the UK
Why choose Mtech Access to support your Medtech Market Access strategy?
- We bring extensive experience from our work with top Medical Device companies, supporting their market access and customer engagement strategy
- We understand the nuances of Medtech market access, but can also utilise our in depth experience with Pharmaceutical and other life sciences clients
- Our in-house developers and designers collaborate directly with our value communication experts, health economists, and medical writers to create your materials – delivering a seamless experience
- We ensure the principles and assumptions behind our approach align with the needs of your customers by consulting with a broad network of payers, clinicians, and other stakeholders across global markets
- In the UK we have close relationships with over 100 contracted Associates working in the NHS, who work directly with us on projects to help ensure our market access strategies and messages will resonate with NHS decision-makers
- We combine evidence and creativity to deliver resources that work for your account managers
- We are a full-service Veeva partner, able to leverage Veeva’s full functionality to deliver the best possible experience for your teams and customers
Articles related to Medtech and Medical Device Market Access
US and European Market Access for Medical Devices – Free Guide
We are delighted to announce that the second edition of our popular introductory guide: ‘Market access stakeholders and processes for medical devices in key European markets’ is now available…
Evidence strategy for Medical Technologies and Diagnostics
Join us for this live webinar on Friday 12th January at 2.00pm (GMT)/3.00pm (CET)/9.00am (EST) where our experts will be exploring evidence strategies for medical devices, diagnostics and digital health.
Market access routes for medical devices: The Innovative Devices Access Pathway (IDAP)
What is IDAP? As the IDAP pilot opens, we explore how this new pathway offers a fast-track route to patient access for innovative medical technologies…